---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-016465"
form_type: "8-K"
ticker: "BTCY"
cik: "0001630113"
company_name: "BIOTRICITY INC."
filed_at: "2021-07-08T23:59:59+00:00"
generated_at: "2026-06-30T06:36:33.188246+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Biotricity issues preliminary Q1 FY2022 revenue guidance: up >45% QoQ

## Summary
- Revenue for Q1 ended June 30, 2021 expected to increase >45% sequentially and >280% YoY.
- This would be the 9th consecutive quarter of revenue growth.
- Customer base expanded to 23 states from 17 states nine months ago.
- CEO cites accelerating sequential growth, high correlation between devices and TaaS revenue.
- Expects consistent triple-digit revenue growth for remainder of fiscal 2022.

## SEC filing metadata
- accession: 0001493152-21-016465
- form_type: 8-K
- ticker: BTCY
- cik: 0001630113
- company_name: BIOTRICITY INC.
- filed_at: 2021-07-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630113/000149315221016465/0001493152-21-016465-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630113/000149315221016465/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-016465
- JSON: https://secwatch.observer/filing/0001493152-21-016465.json
- Plain text: https://secwatch.observer/filing/0001493152-21-016465.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.